Nelarabine Market: Strong Opportunity in Future Due to Increasing Number Adult Cancer Patients: Carbone Scientific, Chemos, Hangzhou Dayangchem
Nelarabine is also known as ARRANON, it is an anti-cancer medicine used to treat adults and children. Nelarabine helps patients with relapsed/refractory T-ALL and T-cell lymphoblastic lymphoma. It is intravenous medicine, which means given through a tube in the patient's vein. This drug has some adverse reactions such as neurologic, Hematologic, Tumor Lysis Syndrome and others. The two major manufacturers are GlaxoSmithKline and Novartis.
View full press release